Shanghai Pharmaceuticals Holding Co. Ltd.SSE: 601607

Announcement on Obtaining Philippine Drug Registration Certificate for Hydroxychloroquine Sulfate Tablets

· Issued by Shanghai Pharmaceuticals Holding Co. Ltd. via Shanghai Stock Exchange

Filed with SSE · · 2 pages · Chinese

Summary by 6ix AI

Shanghai Pharmaceuticals Holding Co. Ltd. announced that it has obtained a drug registration certificate for Hydroxychloroquine Sulfate Tablets from the Philippine Food and Drug Administration, allowing the product to be marketed in the Philippines.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Announcement on Obtaining Philippine Drug Registration Certificate for Hydroxychloroquine Sulfate Tablets

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Shanghai Pharmaceuticals Holding Co. Ltd. on 6ix

Earlier from Shanghai Pharmaceuticals

Later from Shanghai Pharmaceuticals

All Shanghai Pharmaceuticals news releases